复方苦参注射液在治疗直肠癌放化疗患者中的应用

Abstract
Figure/Table
References (15)
Related Citation (15)

Download: PDF (0 KB) HTML (38 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To explore the application of Compound Kushen Injection in the treatment of rectal cancer patients with radiotherapy and chemotherapy.Methods A total of 60 patients with rectal cancer in People′s Hospital of Yichun City,Jiangxi Province from December 2018 to August 2020 were selected as subjece and divited into the control group and the observation group according to the random number table method,with 30 cases in each group.The control group received radiotherapy and chemotherapy treatment,and the observation group received Compound Kushen Injection treatment.Both groups received continuous treatment for 6 weeks.The clinical efficacy of the two groups was compared after treatment.The immune function before and after treatment and the occurrence of adverse reactions during treatment were compared between the two groups.Results The total clinical effective rate of the observation group after treatment was 93.33%,higher than that of the control group of 66.66%,the difference was statistically significant(P＜0.05).The peripheral blood CD4+,CD4+/CD8+ levels of patients of the two groups after treatment were lower than those before treatment,the peripheral blood CD4+ and CD4+/CD8+ levels of the observation group after treatment were higher than those of the control group,the differences were statistically significant(P＜0.05).The peripheral blood CD8+levels of patients in the two group after treatment were higher than those before treatment,and the peripheral blood CD8+ level of the observation group was lower than that of the control group after treatment,and the differences were statistically significant(P＜0.05).There were no significant differences in the levels of peripheral blood CD4+,CD8+,CD4+/CD8+ between the two groups before treatment(P＞0.05).During the treatment period,the total incidence of adverse reactions in the observation group was 30.00%,which was lower than 66.67% in the control group,the difference was statistically significant(P＜0.05).Conclusion Compound Kushen Injection can improve the immune function of patients with rectal cancer,reduce the side effect of radiotherapy and chemotherapy,and can improve the clinical efficacy of radiotherapy and chemotherapy,which is safer.

Key words： Rectal cancer Compound Kushen Injection Chemotherapy Radiotherapy Immune function

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	WANG He
	SHENG Jian-wen
	YIN Wei -hua
	FAN Hui-zhen

Cite this article:

WANG He,SHENG Jian-wen,YIN Wei -hua, et al. Application of Compound Kushen Injection in the treatment of rectal cancer patients with radiotherapy and chemotherapy[J]. 中国当代医药, 2021, 28(26): 123-125转133.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2021/V28/I26/123

[1]	朱英霞.益气健脾汤联合静脉治疗及精确腹腔热灌注化疗治疗晚期结直肠癌患者的临床效果[J].医疗装备，2020，33（24）：132-133.
[2]	高星，孙会群，郭永刚.复方苦参注射液联合化疗治疗晚期结肠癌临床研究[J].辽宁中医杂志，2021，48（3）：128-130.
[3]	孙燕.中国结直肠癌诊疗规范（2017年版）[J].上海医学，2018，41（8）：449-463.
[4]	张萍.实体瘤免疫治疗疗效评价标准[J].国际肿瘤学杂志，2016，43（11）：848-851.
[5]	邹秋萍.中药及活性成分通过影响肠道菌群干预结直肠癌的研究进展[J].国际药学研究杂志，2020，47（12）：1027-1032.
[6]	韩亚民.直肠癌患者外周血循环肿瘤细胞围手术期变化及临床意义[J].中国临床新医学，2020，13（12）：1229-1234.
[7]	马婷.补气益肠方联合化疗治疗结直肠癌术后患者的临床疗效及对其免疫功能的影响[J].世界中西医结合杂志，2020，15（12）：2161-2165，2172.
[8]	杨宇飞.中医药在结直肠癌治疗中的优势与展望[J].中国中西医结合杂志，2020，40（11）：1294-1297.
[9]	李鹏帆.基于网络药理学探讨苦参治疗溃疡性结肠炎的作用机制[J].中医药导报，2020，26（10）：178-185.
[10]	宫艳美.复方苦参注射液联合化疗对直肠癌疗效影响[J].天津药学，2019，31（6）：55-56.
[11]	尹卫华.复方苦参注射液对结直肠癌多药耐药性逆转作用的机制研究[J].时珍国医国药，2019，30（12）：2886-2889.
[12]	马守东，房丽.卡培他滨节拍化疗联合复方苦参注射液治疗晚期结直肠癌的临床疗效观察[J].中国煤炭工业医学杂志，2019，22（4）：351-355.
[13]	海丽娜.血清化学与网络药理学关联研究复方苦参注射液对肝癌小鼠的作用机理[J].中药药理与临床，2020，36（4）：167-172.
[14]	王凌.复方苦参注射液辅治直肠癌同步放化疗所致急性放射性肠炎临床观察[J].实用中医药杂志，2021，37（1）：48-50.
[15]	尹宏，赖思帧.复方苦参注射液联合化疗对结直肠癌患者术后营养状况、免疫功能、炎性因子水平及生活质量的影响[J].中国中西医结合外科杂志，2020，26（3）：457-464.